Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer (PIE)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Amgen
Novartis
Information provided by (Responsible Party):
Amanda Townsend, The Queen Elizabeth Hospital
ClinicalTrials.gov Identifier:
NCT01139138
First received: May 28, 2010
Last updated: February 8, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2017
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)